Omnicell has expanded it existing range of automated medicines management and adherence solutions by entering into an agreement with Hanmi Pharm to distribute innovative tools across the UK’s retail pharmacy market.
The American healthcare technology company says the deal is "in line with Omnicell’s vision and appreciation that the retail pharmacy market wants choice through a more agnostic approach to automated medication adherence solutions."
The South Korean Hanmi Pharm-owned JVM model will support both blister and pouch adherence with the same level of detail and infrastructure Omnicell offers for its full range of solutions.
The model offers a flexible portfolio of hardware – from small desktop to large-scale models capable of handling between 300 to 576 cartridges – enabling it to meet the varying demands of pharmacies and allowing them to scale up or down models to suit their requirements.
“The JVM range of products provides an exceptional new offering for a variety of budgets across the retail pharmacy market, which further demonstrates Omnicell’s commitment to understanding and meeting the needs of our clients,” said Sara Dalmasso, general manager and vice president of Omnicell International.
“The last 18-24 months have placed immense pressure on the sector and this is another step in helping to make the day-to-day working lives of pharmacists easier and more efficient, and ultimately freeing up their valuable time to focus more on face-to-face patient interaction and care.”
The agreement is expected to expand Omnicell’s existing automated medication adherence solutions, while making it more accessible to different users.
Cyrus Hodivala, sales director, UK and Ireland, at Omnicell International, adds: “It is important for us to be constantly evolving our solutions in line with the changing dynamics of the retail pharmacy sector. Joining forces with Hamni Pharm – a leading, global pharmaceutical company – provides a welcome expansion of Omnicell’s portfolio for the UK market.
“With a shared and comprehensive expertise in the automation field, we are confident the new partnership will ensure Omnicell remains at the forefront of automation solutions. By enabling pharmacists to easily scale their business, our solutions will result in immediate improvements in medication adherence and patient outcomes.”
In January, Omnicell acquired Hub and Spoke Innovations.
Graeme Duncan 
